Home / Mesothelioma.net / Phase 2 Mesothelioma Drug Study Yields “Promising” Anti-Tumor Activity

Phase 2 Mesothelioma Drug Study Yields “Promising” Anti-Tumor Activity

Though chemotherapy is considered the gold standard for treating malignant pleural mesothelioma, the aggressive form of cancer is notoriously resilient,...

from Mesothelioma.net https://ift.tt/TrgYmAX
via IFTTT
Phase 2 Mesothelioma Drug Study Yields “Promising” Anti-Tumor Activity Phase 2 Mesothelioma Drug Study Yields “Promising” Anti-Tumor Activity Reviewed by Unknown on November 02, 2023 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.